[{"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "47.00", "Date_of_Payment": "07/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "137676266", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "36.29", "Date_of_Payment": "04/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148729816", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "BYDUREON WEEKLY", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "24.23", "Date_of_Payment": "05/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267676884", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HUMALOG", "Name_of_Associated_Covered_Drug_or_Biological2": "TRADJENTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "23.68", "Date_of_Payment": "02/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267676886", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HUMALOG", "Name_of_Associated_Covered_Drug_or_Biological2": "TRADJENTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "21.49", "Date_of_Payment": "07/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161752556", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Arbor Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005507", "Total_Amount_of_Payment_USDollars": "21.42", "Date_of_Payment": "04/29/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "217627012", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EDARBI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "20.92", "Date_of_Payment": "10/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "205800416", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "QUILLIVANT XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "20.42", "Date_of_Payment": "10/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168925222", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Myrbetriq", "Name_of_Associated_Covered_Drug_or_Biological2": "Vesicare", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "19.78", "Date_of_Payment": "09/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "103237026", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Oseni", "Name_of_Associated_Covered_Drug_or_Biological2": "Kazano", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "19.12", "Date_of_Payment": "12/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339745180", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VIBERZI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "19.12", "Date_of_Payment": "12/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339745184", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VIBERZI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "19.06", "Date_of_Payment": "08/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339739140", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "18.77", "Date_of_Payment": "03/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161110665", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Levemir", "Name_of_Associated_Covered_Drug_or_Biological2": "NovoLog", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "18.52", "Date_of_Payment": "09/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148803868", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Daiichi Sankyo Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000195", "Total_Amount_of_Payment_USDollars": "18.22", "Date_of_Payment": "08/16/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "100859936", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Welchol", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "17.37", "Date_of_Payment": "03/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "155853142", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Nucynta", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "17.30", "Date_of_Payment": "09/19/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "103237024", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Oseni", "Name_of_Associated_Covered_Drug_or_Biological2": "Kazano", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Otsuka America Pharmaceutical, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MD", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010723", "Total_Amount_of_Payment_USDollars": "16.70", "Date_of_Payment": "12/02/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "31923749", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ABILIFY TABLET", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "16.61", "Date_of_Payment": "08/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290863604", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPIRIVA RESPIMAT", "Name_of_Associated_Covered_Drug_or_Biological2": "STIOLTO", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "16.60", "Date_of_Payment": "07/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319881430", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ARNUITY", "Name_of_Associated_Covered_Drug_or_Biological2": "BREO", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "16.40", "Date_of_Payment": "04/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148385348", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON WEEKLY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "16.37", "Date_of_Payment": "06/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150209092", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYMBICORT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "15.95", "Date_of_Payment": "08/22/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "4771635", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HUMALOG", "Name_of_Associated_Covered_Drug_or_Biological2": "TRADJENTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "15.74", "Date_of_Payment": "08/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "340500338", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TEFLARO", "Name_of_Associated_Covered_Drug_or_Biological2": "DALVANCE", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "15.07", "Date_of_Payment": "04/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "161261914", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "14.91", "Date_of_Payment": "06/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319023160", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TOUJEO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "14.61", "Date_of_Payment": "09/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "162433258", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Victoza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "14.61", "Date_of_Payment": "05/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260076228", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYMBICORT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "14.23", "Date_of_Payment": "05/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "293711350", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZECUITY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "14.10", "Date_of_Payment": "08/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148329840", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON WEEKLY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "14.08", "Date_of_Payment": "10/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323009000", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "14.08", "Date_of_Payment": "12/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323738214", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "14.08", "Date_of_Payment": "10/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323271554", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LYRICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "14.02", "Date_of_Payment": "12/19/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23817935", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "13.61", "Date_of_Payment": "09/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198724888", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "13.57", "Date_of_Payment": "11/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290863596", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SYNJARDY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "13.48", "Date_of_Payment": "11/01/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "13971696", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "13.48", "Date_of_Payment": "05/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339408742", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "13.29", "Date_of_Payment": "07/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "155853148", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Nucynta", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "13.25", "Date_of_Payment": "12/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "6693517", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "12.79", "Date_of_Payment": "04/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "193530020", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "Oseni", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "12.52", "Date_of_Payment": "08/16/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184576574", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Belviq", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "EISAI INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "12.39", "Date_of_Payment": "03/24/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "338034954", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BELVIQ", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "12.22", "Date_of_Payment": "11/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297250400", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Prolia", "Name_of_Associated_Covered_Drug_or_Biological2": "Repatha", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "12.16", "Date_of_Payment": "10/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339329462", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "NAMZARIC", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "12.03", "Date_of_Payment": "02/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339314874", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novo Nordisk Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000144", "Total_Amount_of_Payment_USDollars": "12.01", "Date_of_Payment": "08/27/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "32337882", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NovoLog", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI PASTEUR INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "11.85", "Date_of_Payment": "02/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318691897", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MENACTRA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTACEL", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "11.80", "Date_of_Payment": "10/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290952698", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JARDIANCE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "11.63", "Date_of_Payment": "06/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148600050", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Kowa Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "AL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005379", "Total_Amount_of_Payment_USDollars": "11.55", "Date_of_Payment": "10/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "223582462", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIVALO", "Name_of_Associated_Covered_Drug_or_Biological2": "VASCEPA", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "11.43", "Date_of_Payment": "01/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "336849864", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Contrave", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "11.40", "Date_of_Payment": "10/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23817933", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "Invokana", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "11.26", "Date_of_Payment": "05/14/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "173448696", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AMRIX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "11.26", "Date_of_Payment": "09/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290863600", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GLYXAMBI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "10.98", "Date_of_Payment": "05/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149839428", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Otsuka America Pharmaceutical, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MD", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010723", "Total_Amount_of_Payment_USDollars": "10.95", "Date_of_Payment": "01/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "216223804", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ABILIFY TABLET", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "10.82", "Date_of_Payment": "09/24/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339201368", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "NAMZARIC", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "10.69", "Date_of_Payment": "03/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148585736", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARXIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "10.65", "Date_of_Payment": "12/04/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "6693516", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "10.40", "Date_of_Payment": "01/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148176722", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ONGLYZA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "10.16", "Date_of_Payment": "10/01/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184576578", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Belviq", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "9.17", "Date_of_Payment": "06/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339116282", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "8.57", "Date_of_Payment": "05/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "193530010", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "8.20", "Date_of_Payment": "09/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "193530028", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "Oseni", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "7.65", "Date_of_Payment": "11/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "193530032", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "Oseni", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "7.33", "Date_of_Payment": "01/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339060150", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "7.13", "Date_of_Payment": "08/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "193530024", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nesina", "Name_of_Associated_Covered_Drug_or_Biological2": "Oseni", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "6.53", "Date_of_Payment": "02/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339039430", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FETZIMA", "Name_of_Associated_Covered_Drug_or_Biological2": "VIIBRYD", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "5.53", "Date_of_Payment": "04/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339015322", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "5.00", "Date_of_Payment": "09/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148743516", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BYDUREON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Journal Article"}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "2.85", "Date_of_Payment": "07/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "155853146", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Aciphex", "Name_of_Associated_Covered_Drug_or_Biological2": "Remicade", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "1.81", "Date_of_Payment": "03/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "155853140", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Nucynta", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "1.60", "Date_of_Payment": "08/23/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "4769937", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRADJENTA", "Name_of_Associated_Covered_Drug_or_Biological2": "HUMALOG", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "0.69", "Date_of_Payment": "05/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "338867370", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "200480", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.53", "Date_of_Payment": "07/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "155853144", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Aciphex", "Name_of_Associated_Covered_Drug_or_Biological2": "Remicade", "Contextual_Information": ""}]